• Login
• Register

HARDWARE AND SOFTWARE SPECIFICATIONS NEEDED TO VIEW SITE

This course requires Windows Operating Systems (95/98, NT, 2000, ME, XP), version 5.5 browsers or higher from Microsoft or Netscape.

Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Macromedia Flash, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of Continuing Medical Education (EOCME) and Excerpta Medica, Inc. The EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians.

CREDIT DESIGNATION STATEMENT

The EOCME designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

DISCLOSURES

As a sponsor accredited by the ACCME, it is the policy of the EOCME to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty of this CME activity disclose the following:

RESOLUTION OF CONFLICT OF INTEREST

The EOCME has implemented a process to resolve conflicts of interest for each CME activity. In order to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public, the EOCME has resolved the conflict by External Content Review.

UNAPPROVED/OFF-LABEL USE DISCLOSURE

The EOCME requires CME faculty to disclose to the participants:

1. When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and
2. Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

Faculty may discuss information about pharmaceutical agents that is outside of FDA-approved labeling. This information is intended solely for CME and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

INTENDED AUDIENCE

This activity has been developed for cardiologists, internists, hospitalists, and other health care providers who treat patients in a hospital setting.

PROGRAM GOALS

The goals of this activity are to understand risk stratification and develop optimal antithrombotic therapeutic regimens when treating non–ST-elevation myocardial infarction (NSTEMI) patients.

EDUCATIONAL OBJECTIVES

• Select treatment options for patients who present with NSTEMI based on risk stratification
• Describe the rationale for selection of an optimal therapeutic regimen of antiplatelet and antithrombin agents
• Relate current recommendations for treatment to specific patient profiles
• Discuss the impact of recent clinical trials on use of low-molecular-weight heparin (LMWH), anti-Xa agents, direct thrombin inhibitors, and glycoprotein (GP) IIb/IIIa inhibitors
• Evaluate current practice standards to determine accordance with guideline recommendations regarding treatment of patients with NSTEMI acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI) or being treated medically
• Perform analysis on clinical practice settings to evaluate if appropriate therapies are being utilized

FINANCIAL SUPPORT

This CME activity is supported by an educational grant from sanofi-aventis U.S.

CME PLANNING COMMITTEE

SPECIAL NEEDS

We encourage participation by all individuals. If you have any special needs, please contact Shaifali Patel at (908) 547-2184, or s.patel@elsevier.com for assistance.